Ironwood Pharmaceuticals | 销售和管理费用



金融业
股票价格
USD
资产
USD 396.06M
现金及等价物
USD 140.41M
销售成本
USD 29.83M
流动资产
USD 273.84M
流动负债
USD 242.5M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD -0.01
股本和储备
USD -264.16M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 535.3M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
USD 204.24
税前利润
USD 68.02M
销售收入
USD 47.71M
销售和管理费用
USD 33.33M
贸易债权人
USD 1.61M
应收帐款人
USD 81.89M


销售和管理费用 更改 日
Acadia Pharmaceuticals USD 146.73M 21.82M 2025-12
Agios Pharmaceuticals USD 42.97M 1.7M 2025-12
Akebia Therapeutics USD 25.74M 1.93M 2025-03
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Amarin USD 17.94M 17.86M 2025-09
Ardelyx USD 83.61M 378K 2025-09
Astellas Pharma JPY 221.78B 14.94B 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Coherus Biosciences USD 26.02M 8.57M 2025-03
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Esperion Therapeutics USD 39.98M 4.21M 2024-09
Exact Sciences USD 491.64M 35.94M 2025-09
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Incyte USD 390.41M 61.33M 2025-12
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Karyopharm Therapeutics USD 27.19M 442K 2024-12
Lexicon Pharmaceuticals USD 39.19M 7.13M 2024-06
MacroGenics USD 9.9M 600K 2025-09
Moderna USD 308M 40M 2025-12
Myriad Genetics USD 129M 1.3M 2025-09
Pacira USD 91.87M 70K 2025-12
PTC Therapeutics USD 87.2M 3.15M 2025-12
Puma Biotechnology USD 16.82M 8.15M 2024-09
Sarepta Therapeutics USD 105.38M 28.27M 2025-12
Takeda JPY 282.78B 29.23B 2025-12
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12


Ironwood Pharmaceuticals 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.